<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39417967</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2584</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>International urology and nephrology</Title><ISOAbbreviation>Int Urol Nephrol</ISOAbbreviation></Journal><ArticleTitle>Intensive care unit continuous kidney replacement therapy: time to change dosage recommendations?</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11255-024-04197-0</ELocationID><Abstract><AbstractText>Continuous kidney replacement therapy (CKRT) is the predominant form of acute kidney support used for hemodynamically unstable adult ICU patients with severe AKI (KDIGO stage 3). The success of CKRT depends on the achieved doses. Practice patterns worldwide are highly variable. A contemporary understanding of treatment adequacy is essential. The KDIGO AKI clinical guidelines recommend delivering effluent volumes of 20-25 ml/kg/hour for CKRT in the ICU setting, with the caveat that higher prescribed doses (25-30 ml(kg/h) may be necessary to achieve adequate delivered CKRT doses. The reference landmark trials provide definitive evidence that increases of delivered CKRT doses beyond the recommended dose are not beneficial for unselected ICU patients with severe AKI. However, the minimum delivered CKRT intensity at which underdosing becomes harmful remains unknown. The answer to this question has clinical relevance (dosing of critically ill patients with obesity or Covid-19 disease, minimizing adverse effects of CKRT) and a relevant impact on the costs of CKRT. The delivered dose of CKRT for Japanese ICU patients with severe AKI has been generally smaller (median 15 ml/h/kg) than the recommended delivered KDIGO dose. The most recently published retrospective cohort study by Okamoto et al. demonstrated that low delivered CKRT doses were associated with a higher mortality among critically ill patients with severe AKI. These data challenge the nation-wide accepted hypothesis that a lower limit of delivered CKRT (&lt; 20 ml/ kg/h) may adequately control uremia/volume overload. Thus, there is an unmet clinical need for prospective randomized trials defining the minimal effective dose of CKRT. Given the dynamic nature of the precipitating critical illness and the natural course of most episodes of AKI, CKRT dose targets are likely to vary. Doses should be tailored to the needs of the individual patient within the limits of the KDIGO guideline recommendations. The Japanese experience with low-dose CKRT is not practice changing.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schiffl</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV, University Hospital Munich, Ziemssenstr.3, D 80336, Munich, Germany. h-schiffl@t-online.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int Urol Nephrol</MedlineTA><NlmUniqueID>0262521</NlmUniqueID><ISSNLinking>0301-1623</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Continuous kidney replacement therapy</Keyword><Keyword MajorTopicYN="N">Lower limit of delivered dose</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>11</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39417967</ArticleId><ArticleId IdType="doi">10.1007/s11255-024-04197-0</ArticleId><ArticleId IdType="pii">10.1007/s11255-024-04197-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Group KDIGO (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2(Suppl):1–138</Citation></Reference><Reference><Citation>Garnier F, Couchoud C, Landais P, Moranne O (2019) Increased incidence of acute kidney injury requiring dialysis in metropolitan France. PLoS ONE 14(2):e0211541. https://doi.org/10.1371/journal.pone.0211541</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0211541</ArticleId><ArticleId IdType="pmc">6366739</ArticleId></ArticleIdList></Reference><Reference><Citation>Khadzhynov D, Schmidt D, Hardt J, Rauch G, Gocke P, Eckardt KU, Schmidt-Ott KM (2019) The incidence of acute kidney injury and associated hospital mortality. Dtsch Arztebl Int 116(22):397–404. https://doi.org/10.3238/arztebl.2019.0397</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2019.0397</ArticleId><ArticleId IdType="pmc">6676729</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, Goldstein SL, Cerdá J, Chawla LS (2018) Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol 14(10):607–625. https://doi.org/10.1038/s41581-018-0052-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-018-0052-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard J, Acharya A, Cerda J, Maccariello ER, Madarasu RC, Tolwani AJ, Liang X, Fu P, Liu ZH, Mehta RL (2015) A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol 10(8):1324–1331. https://doi.org/10.2215/cjn.04360514</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/cjn.04360514</ArticleId><ArticleId IdType="pmc">4527019</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewa OG, Ortiz-Soriano V, Lambert J, Kabir S, Heung M, House AA, Monga D, Juncos LA, Secic M, Piazza R, Goldstein SL, Bagshaw SM, Neyra JA (2023) Epidemiology and outcomes of AKI treated with continuous kidney replacement therapy: The Multicenter CRRTnet Study. Kidney Med 5(6):100641. https://doi.org/10.1016/j.xkme.2023.100641</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xkme.2023.100641</ArticleId><ArticleId IdType="pmc">10238597</ArticleId></ArticleIdList></Reference><Reference><Citation>James MT, Bhatt M, Pannu N, Tonelli M (2020) Long-term outcomes of acute kidney injury and strategies for improved care. Nat Rev Nephrol 16(4):193–205. https://doi.org/10.1038/s41581-019-0247-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-019-0247-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Bellomo R, Burdmann EA, Doi K, Endre ZH, Goldstein SL, Kane-Gill SL, Liu KD, Prowle JR, Shaw AD, Srisawat N, Cheung M, Jadoul M, Winkelmayer WC, Kellum JA (2020) Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int 98(2):294–309. https://doi.org/10.1016/j.kint.2020.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.04.020</ArticleId><ArticleId IdType="pmc">8481001</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361(17):1627–1638. https://doi.org/10.1056/NEJMoa0902413</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0902413</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359(1):7–20. https://doi.org/10.1056/NEJMoa0802639</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0802639</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S, Ricci Z, Ronco C (2018) CRRT for sepsis-induced acute kidney injury. Curr Opin Crit Care 24(6):483–492. https://doi.org/10.1097/MCC.0000000000000544</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0000000000000544</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin BR, Thomson A, Yoder M, Francis I, Ambruso S, Bregman A, Feller M, Johnson-Bortolotto S, King C, Bonnes D, Dufficy L, Wu C, Bansal A, Tad YD, Faubel S, Jalal D (2019) Continuous renal replacement therapy dosing in critically Ill patients: a quality improvement initiative. Am J Kidney Dis 74(6):727–735. https://doi.org/10.1053/j.ajkd.2019.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2019.06.013</ArticleId><ArticleId IdType="pmc">6939344</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffl H (2007) Disease severity adversely affects delivery of dialysis in acute renal failure. Nephron Clin Pract 107(4):c163-169. https://doi.org/10.1159/000110592</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000110592</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffl H, Lang SM (2021) Current approach to successful liberation from renal replacement therapy in critically Ill patients with severe acute kidney injury: the quest for biomarkers continues. Mol Diagn Ther 25(1):1–8. https://doi.org/10.1007/s40291-020-00498-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40291-020-00498-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells M, Goldstein LN, Alter SM, Solano JJ, Engstrom G, Shih RD (2024) The accuracy of total body weight estimation in adults—A systematic review and meta-analysis. Am J Emerg Med 76:123–135. https://doi.org/10.1016/j.ajem.2023.11.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2023.11.037</ArticleId></ArticleIdList></Reference><Reference><Citation>Lameire N, Van Biesen W, Vanholder R (2009) Dose of dialysis in the intensive care unit: is the venom in the dose or in the clinical experience? Crit Care 13(3):155. https://doi.org/10.1186/cc7873</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7873</ArticleId><ArticleId IdType="pmc">2717425</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínez-Camacho M, Jones-Baro RA, Gómez-González A, Morales-Hernández D, Lugo-García DS, Melo-Villalobos A, Navarrete-Rodríguez CA, Delgado-Camacho J (2024) Physical and respiratory therapy in the critically ill patient with obesity: a narrative review. Front Med (Lausanne) 11:1321692. https://doi.org/10.3389/fmed.2024.1321692</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2024.1321692</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters BJ, Barreto EF, Mara KC, Kashani KB (2023) Continuous renal replacement therapy and mortality in critically Ill obese adults. Crit Care Explor 5(11):e0998. https://doi.org/10.1097/cce.0000000000000998</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/cce.0000000000000998</ArticleId><ArticleId IdType="pmc">10833633</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurmohamed SA, Koning MV, Vervloet MG, Groeneveld AB (2011) Delivered dose of continuous venovenous hemofiltration predicts outcome in septic patients with acute kidney injury: a retrospective study. J Crit Care 26(2):213–220. https://doi.org/10.1016/j.jcrc.2010.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2010.09.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffl H, Lang SM, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346(5):305–310. https://doi.org/10.1056/NEJMoa010877</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa010877</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang HL, Xue WJ, Li DQ, Yin AP, Xin X, Li CM, Gao JL (2005) Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 11(31):4815–4821. https://doi.org/10.3748/wjg.v11.i31.4815</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v11.i31.4815</ArticleId><ArticleId IdType="pmc">4398728</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi K, Nishida O, Shigematsu T, Sadahiro T, Itami N, Iseki K, Yuzawa Y, Okada H, Koya D, Kiyomoto H, Shibagaki Y, Matsuda K, Kato A, Hayashi T, Ogawa T, Tsukamoto T, Noiri E, Negi S, Kamei K, Kitayama H, Kashihara N, Moriyama T, Terada Y, Japanese Clinical Practice Guideline for Acute Kidney Injury C (2018) The Japanese Clinical Practice Guideline for acute kidney injury 2016. J Intensive Care 6:48. https://doi.org/10.1186/s40560-018-0308-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-018-0308-6</ArticleId><ArticleId IdType="pmc">6088399</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada H, Yanagita M (2022) Global perspectives in acute kidney injury: Japan. Kidney360 3(6):1099–1104. https://doi.org/10.34067/kid.0007892021</Citation><ArticleIdList><ArticleId IdType="doi">10.34067/kid.0007892021</ArticleId><ArticleId IdType="pmc">9255879</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda H, Uchino S, Uji M, Ohnuma T, Namba Y, Katayama S, Kawarazaki H, Toki N, Takeda K, Izawa J, Tokuhira N, Nagata I (2014) The lower limit of intensity to control uremia during continuous renal replacement therapy. Crit Care 18(5):539. https://doi.org/10.1186/s13054-014-0539-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0539-4</ArticleId><ArticleId IdType="pmc">4194053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawarazaki H, Uchino S (2016) Validity of low-efficacy continuous renal replacement therapy in critically ill patients. Anaesthesiol Intensive Ther 48(3):191–196. https://doi.org/10.5603/AIT.a2016.0029</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/AIT.a2016.0029</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Toki N, Takeda K, Ohnuma T, Namba Y, Katayama S, Kawarazaki H, Yasuda H, Izawa J, Uji M, Tokuhira N, Nagata I, Japanese Society for P, Trainees in Intensive Care Clinical Trial G (2013) Validity of low-intensity continuous renal replacement therapy. Crit Care Med. https://doi.org/10.1097/CCM.0b013e318298622e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318298622e</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Namba Y, Fujitani S, Sasaki J, Narihara K, Shibagaki Y, Uchino S, Taira Y (2012) Low-dose continuous renal replacement therapy for acute kidney injury. Int J Artif Organs 35(7):525–530. https://doi.org/10.5301/ijao.5000110</Citation><ArticleIdList><ArticleId IdType="doi">10.5301/ijao.5000110</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto K, Fukushima H, Kawaguchi M, Tsuruya K (2024) Low-dose continuous kidney replacement therapy and mortality in critically Ill patients with acute kidney injury: a retrospective cohort study. Am J Kidney Dis. https://doi.org/10.1053/j.ajkd.2024.01.526</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2024.01.526</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerdá J, Ronco C (2009) Modalities of continuous renal replacement therapy: technical and clinical considerations. Semin Dial 22(2):114–122. https://doi.org/10.1111/j.1525-139X.2008.00549.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-139X.2008.00549.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Reis T, Husain-Syed F, Vanholder R, Hutchison C, Stenvinkel P, Blankestijn PJ, Cozzolino M, Juillard L, Kashani K, Kaushik M, Kawanishi H, Massy Z, Sirich TL, Zuo L, Ronco C (2021) Classification of uremic toxins and their role in kidney failure. Clin J Am Soc Nephrol 16(12):1918–1928. https://doi.org/10.2215/cjn.02660221</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/cjn.02660221</ArticleId><ArticleId IdType="pmc">8729494</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T (2023) Low-intensity versus medium-intensity continuous kidney replacement therapy for critically ill patients (LIMIT). A multicenter randomized clinical trial. Clin Trials gov:NCT 06014801</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>